Showing results (81-90 of 467) with videos related to
Sort By:
Pageof 47
The Journal of Allergy and Clinical Immunology|April 29, 2020
Eosinophil responses during COVID-19 infections and coronavirus vaccinationAndrew W Lindsley, Justin T Schwartz, Marc E RothenbergImmunology Letters|January 13, 2006
The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activationIsabelle Isnardi, Pierre Bruhns, Georges Bismuth, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Human basophils express the glycosylphosphatidylinositol-anchored low-affinity IgG receptor FcgammaRIIIB (CD16B)Nihad Meknache, Friederike Jönsson, Jérôme Laurent, et al.Expert Review of Clinical Immunology|March 13, 2020
Recent advances in potential targets for eosinophilic esophagitis treatmentsSalvatore Oliva, Nurit P Azouz, Laura Stronati, et al.The Journal of Allergy and Clinical Immunology|March 30, 2024
Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseasesTetsuo Shoda, Richard J Taylor, Naoya Sakai, et al.Gastroenterology|September 7, 2005
Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in miceHiroko Saito Akei, Anil Mishra, Carine Blanchard, et al.Nature Reviews. Gastroenterology & Hepatology|June 18, 2025
The oesophagus as an immune organMark Rochman, Kendall Kellerman, Michael P Jankowski, et al.The Journal of Allergy and Clinical Immunology|May 15, 2026
Emerging Insights into the Presentation, Pathophysiology, and Management of Eosinophilic EsophagitisMia A Natale, Ria Jindal, Marc E Rothenberg, et al.Nature|October 4, 2019
Harnessing innate immunity in cancer therapyOlivier Demaria, Stéphanie Cornen, Marc Daëron, et al.Nature|November 21, 2019
Publisher Correction: Harnessing innate immunity in cancer therapyOlivier Demaria, Stéphanie Cornen, Marc Daëron, et al.Pageof 47